Aier Eye Hospital Group Co (300015) H1 2024 earnings summary

Executive summary

• Revenue for H1 2024 reached ¥10.55 billion, up 2.86% year-over-year; net profit attributable to shareholders rose 19.71% to ¥2.05 billion.

• Operating profit increased 7.65% year-over-year to ¥2.72 billion; net profit margin improved to 20.95%.

• Outpatient visits grew 9.23% and surgeries 6.92% year-over-year, reflecting robust demand.

• The company expanded its network to 311 domestic hospitals and 202 clinics, and completed 52 acquisitions in the period.

• International expansion included the acquisition of the UK’s Optimax Group, strengthening global presence.

Financial highlights

• Revenue: ¥10.55 billion, up 2.86% year-over-year.

• Net profit attributable to shareholders: ¥2.05 billion, up 19.71% year-over-year.

• Operating profit: ¥2.72 billion, up 7.65% year-over-year.

• Basic EPS: ¥0.2224, up 21.13% year-over-year.

• Net cash from operating activities: ¥2.84 billion, down 15.61% year-over-year.

Outlook and guidance

• Management expects continued growth as economic recovery boosts demand for ophthalmic services.

• The company will focus on digital transformation, talent development, and internationalization.

• No interim dividend, bonus shares, or capital increase from reserves planned for H1 2024.